153 related articles for article (PubMed ID: 21372204)
1. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.
Ciampa J; Yeager M; Amundadottir L; Jacobs K; Kraft P; Chung C; Wacholder S; Yu K; Wheeler W; Thun MJ; Divers WR; Gapstur S; Albanes D; Virtamo J; Weinstein S; Giovannucci E; Willett WC; Cancel-Tassin G; Cussenot O; Valeri A; Hunter D; Hoover R; Thomas G; Chanock S; Chatterjee N
Cancer Res; 2011 May; 71(9):3287-95. PubMed ID: 21372204
[TBL] [Abstract][Full Text] [Related]
2. Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.
Ciampa J; Yeager M; Jacobs K; Thun MJ; Gapstur S; Albanes D; Virtamo J; Weinstein SJ; Giovannucci E; Willett WC; Cancel-Tassin G; Cussenot O; Valeri A; Hunter D; Hoover R; Thomas G; Chanock S; Holmes C; Chatterjee N
Hum Hered; 2011; 72(3):182-93. PubMed ID: 22086326
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Jin G; Zheng SL; Lilja H; Kim ST; Tao S; Gao Z; Young T; Wiklund F; Feng J; Isaacs WB; Rittmaster RS; Gronberg H; Condreay LD; Sun J; Xu J
Neoplasia; 2013 Jan; 15(1):95-101. PubMed ID: 23359319
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
Shen J; Li Z; Song Z; Chen J; Shi Y
Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
[TBL] [Abstract][Full Text] [Related]
6. Multiple loci on 8q24 associated with prostate cancer susceptibility.
Al Olama AA; Kote-Jarai Z; Giles GG; Guy M; Morrison J; Severi G; Leongamornlert DA; Tymrakiewicz M; Jhavar S; Saunders E; Hopper JL; Southey MC; Muir KR; English DR; Dearnaley DP; Ardern-Jones AT; Hall AL; O'Brien LT; Wilkinson RA; Sawyer E; Lophatananon A; ; ; Horwich A; Huddart RA; Khoo VS; Parker CC; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Cooper C; Donovan JL; Hamdy FC; Neal DE; Eeles RA; Easton DF
Nat Genet; 2009 Oct; 41(10):1058-60. PubMed ID: 19767752
[TBL] [Abstract][Full Text] [Related]
7. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.
Dimitrakopoulou VI; Travis RC; Shui IM; Mondul A; Albanes D; Virtamo J; Agudo A; Boeing H; Bueno-de-Mesquita HB; Gunter MJ; Johansson M; Khaw KT; Overvad K; Palli D; Trichopoulou A; Giovannucci E; Hunter DJ; Lindström S; Willett W; Gaziano JM; Stampfer M; Berg C; Berndt SI; Black A; Hoover RN; Kraft P; Key TJ; Tsilidis KK
Am J Epidemiol; 2017 Mar; 185(6):452-464. PubMed ID: 28399564
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to prostate cancer in Taiwan: A genome-wide association study.
Bau DT; Tsai CW; Chang WS; Yang JS; Liu TY; Lu HF; Wang YW; Tsai FJ
Mol Carcinog; 2024 Apr; 63(4):617-628. PubMed ID: 38390760
[TBL] [Abstract][Full Text] [Related]
9. Association between metformin medication, genetic variation and prostate cancer risk.
Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
13. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
15. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
16. Two independent prostate cancer risk-associated Loci at 11q13.
Zheng SL; Stevens VL; Wiklund F; Isaacs SD; Sun J; Smith S; Pruett K; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Johansson JE; Liu W; Kim JW; Chang BL; Duggan D; Carpten J; Rodriguez C; Isaacs W; Grönberg H; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1815-20. PubMed ID: 19505914
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility loci associated with prostate cancer progression and mortality.
Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K
Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
Ishak MB; Giri VN
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility loci, pesticide exposure and prostate cancer risk.
Koutros S; Berndt SI; Hughes Barry K; Andreotti G; Hoppin JA; Sandler DP; Yeager M; Burdett LA; Yuenger J; Alavanja MC; Beane Freeman LE
PLoS One; 2013; 8(4):e58195. PubMed ID: 23593118
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of prostate cancer mortality.
Penney KL; Pyne S; Schumacher FR; Sinnott JA; Mucci LA; Kraft PL; Ma J; Oh WK; Kurth T; Kantoff PW; Giovannucci EL; Stampfer MJ; Hunter DJ; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2869-76. PubMed ID: 20978177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
